FDA-cleared AI Sonio offers FDA 510(k) cleared AI-powered ultrasound workflow and reporting enhancements, presenting a proven risk-reduction angle for procurement and compliance teams seeking validated AI tools in prenatal imaging.

US market expansion Recent US market activities, including leadership hires and product launches, indicate an active expansion into US healthcare providers, offering sales opportunities with hospitals and clinics seeking integrated obstetrics AI solutions.

Maternal-fetal focus With emphasis on maternal and fetal health, Sonio positions itself for sales in obstetrics departments, maternal-fetal medicine specialists, and ultrasound labs aiming to improve examination completeness, documentation quality, and efficiency.

SF-Detect growth The launch of the third version of Sonio Detect and expanded AI image evaluation capabilities create upsell/downsell opportunities for existing customers and new accounts requiring advanced image analysis and QA workflows.

Global regulatory ready CE marking for Sonio Detect and ongoing regulatory milestones support cross-border sales strategies, enabling conversations with healthcare providers in regions requiring regulatory clearance and quality assurance adherence.